Cancer control research focuses on reducing the burden of cancer through prevention, early detection, treatment, and survivorship care. Our research experts study strategies that improve outcomes and reduce health disparities, ensuring patients and communities benefit from advances in care.
Dr. Xiao Hu is leading a study on genomic testing access in lung cancer patients in Maine, supported by an American Cancer Society Institutional Research Grant subaward from Dartmouth College. The research team will examine how comprehensive genomic tests are used, explore potential disparities in access, and analyzes which test combinations—such as tissue vs. tissue plus blood, or DNA vs. DNA plus RNA sequencing—help patients start treatment faster.
